Home » Conferences & Events » Health Care » Drug Discovery and Development

Drug Discovery and Development

Orphan Drugs: Making Rare Disease Rarer
February 12, 2013

From the 15th Annual BIO CEO & Investor Conference at the Waldorf Astoria Hotel in New...

Clinical Trials Modernization Initiative
September 19, 2012

In an effort to bring innovative new medicines to patients more efficiently, while protecting...

Bringing Innovation to Neglected Disease Research and Development: Joint Report by BIO and BIO Ventures for Global Health
June 17, 2012

BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) have...

Podcast Part I: John Sterling, Editor in Chief of Genetic Engineering and Biotechnology News (GEN)
April 26, 2012

John discusses the state of the industry and what he expects will be the top three issues...

More Articles →

Letters, Testimony & Comments

Cell and Gene Therapy: BIO Comments on Preclinical Assessment of Investigational Cellular and Gene Therapy Products
February 27 2013
    Dear Sir/Madam:    The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration...
SMU: BIO Statement on Creating an Alternative Approval Pathway for Certain Drugs Intended to Address Unmet Medical Need
February 4 2013
  The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to provide...
BIO Comments on ANVISA Public Consultation N°66/2012
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
IRB: BIO Comments on Draft Guidance for IRBs
January 22 2013
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
Accelerated Approval: BIO Comments on pCR in Neoadjuvant Treatment for Breast Cancer
July 29 2012
  Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the...
More Letters, Testimony & Comments →

Press Releases

IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
July 23 2012
Groups Issue Booklet to Help Biotechnology and Pharmaceutical Companies Identify Pipeline Medicines with Doping...
BIO Supports Permanent Reauthorization of Programs to Encourage Development of Lifesaving Medications for Children
March 28 2012
Washington, D.C. (March 28, 2012) – BIO President and CEO Jim Greenwood issued the following statement in...
BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit
May 25 2011
WASHINGTON, D.C. (Wednesday, May 25, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Representative Upton Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
Senator Casey Honored as BIO Legislator of the Year
May 4 2011
Pennsylvania Bio President Christopher Molineaux and BIO President and CEO Jim Greenwood present Senator...
More Press Releases →